RESUMEN
A group of 11 enzyme families of metalophosphohydrolases called phosphodiesterases (PDEs) is responsible for a hydrolysis of intracellular cAMP and cGMP. Xanthine derivatives (methylxanthines) inhibit PDEs without selective action on their single isoforms and lead to many pharmacological effects, e.g. bronchodilation, anti-inflammatory and immunomodulating effects, and thus they can modulate the cough reflex. Contrary, selective PDE inhibitors have been developed to inhibit PDE isoforms with different pharmacological effects based on their tissue expression. In this paper, effects of non-selective PDE inhibitors (e.g. theophylline) are discussed, with a description of other putative mechanisms in their effects on cough. Antitussive effects of selective inhibitors of several PDE isoforms are reviewed, focusing on PDE1, PDE3, PDE4, PDE5 and PDE7. The inhibition of PDEs suggests participation of bronchodilation, suppression of TRPV channels and anti-inflammatory action in cough suppression. Selective PDE3, PDE4 and PDE5 inhibitors have demonstrated the most significant cough suppressive effects, confirming their benefits in chronic inflammatory airway diseases associated with bronchoconstriction and cough.
Asunto(s)
Antitusígenos/uso terapéutico , Tos/tratamiento farmacológico , Inhibidores de Fosfodiesterasa/uso terapéutico , Animales , Antitusígenos/farmacología , Tos/enzimología , Humanos , Inhibidores de Fosfodiesterasa/farmacologíaRESUMEN
OBJECTIVE: Asthma is a common chronic disease associated with altered proteolytic activity. The present study tested the hypothesis that altered protease concentration in amniotic fluid (AF), an index of airway fluid at birth, precedes early cough and wheeze. METHODS: AF was collected and analysed for the following: matrix metalloproteinases (MMP) -2, -8 and -9, tissue inhibitor of metalloproteinases (TIMP) -1 and 2, plasminogen activator inhibitor (PAI)-1. Infant were followed up at ages 1, 2 and 3 years. RESULTS: Samples of AF were obtained in 92 infants. There were inconsistent and relatively small differences in some analytes between those individuals with and without symptoms at ages one and two years. PAI-1 concentrations were reduced in association with cough at age 1 year (p = 0.035). Reduced MMP-8:TIMP-2 ratio was associated with wheeze at age 2 years (p = 0.038). There were no associations between AF analytes and symptoms at 3 years of age. CONCLUSION: There is heterogeneity in concentrations of proteases and their inhibitors in airways at birth but in this exploratory study, there was no consistent evidence that protease concentration at birth was important to later respiratory symptoms.
Asunto(s)
Líquido Amniótico/enzimología , Asma/etiología , Colagenasas/metabolismo , Tos/etiología , Inhibidores de Proteasas/metabolismo , Ruidos Respiratorios/etiología , Asma/enzimología , Cesárea , Preescolar , Tos/enzimología , Procedimientos Quirúrgicos Electivos , Femenino , Estudios de Seguimiento , Humanos , Lactante , Masculino , Embarazo , Nacimiento a TérminoRESUMEN
IL-2-inducible T-cell kinase (ITK) deficiency is a rare inherited immunodeficiency disease characterized by homozygous mutations in the ITK gene and the inability to control Epstein-Barr virus (EBV) infection leading to EBV-associated lymphoproliferative disorders of B cell origin. Many aspects of its clinical presentation and immunologic phenotype are still unclear to clinicians. We report on a 14-year-old female patient with complaints of an 8-month history of cough and fever. Imaging studies revealed diffuse pulmonary nodules and mediastinal lymphadenopathy. Transbronchial lung biopsy showed nonmalignant polyclonal B cell proliferation. High titers of EBV DNA were detected by PCR analysis in bronchoalveolar lavage fluid, bone marrow, and blood. Genomic analysis revealed a homozygous single base pair deletion in exon 5 of the ITK gene (c.468delT) in this patient. Treatment with rituximab (anti-CD20 mab) resulted in complete clinical remission with resolution of pulmonary lesions and a negative EBV titer in serum. All patients with EBV-associated lymphoproliferative disorders should be analyzed for mutations in ITK.
Asunto(s)
Infecciones por Virus de Epstein-Barr/enzimología , Neumonía Viral/enzimología , Proteínas Tirosina Quinasas/genética , Adolescente , Anticuerpos Monoclonales de Origen Murino/uso terapéutico , Linfocitos B/efectos de los fármacos , Linfocitos B/patología , Linfocitos B/virología , Líquido del Lavado Bronquioalveolar/virología , Tos/diagnóstico , Tos/tratamiento farmacológico , Tos/enzimología , Tos/patología , Tos/virología , ADN Viral/análisis , Infecciones por Virus de Epstein-Barr/tratamiento farmacológico , Infecciones por Virus de Epstein-Barr/patología , Femenino , Fiebre/diagnóstico , Fiebre/tratamiento farmacológico , Fiebre/enzimología , Fiebre/patología , Fiebre/virología , Humanos , Factores Inmunológicos/uso terapéutico , Pulmón/diagnóstico por imagen , Pulmón/efectos de los fármacos , Pulmón/enzimología , Pulmón/patología , Pulmón/virología , Activación de Linfocitos/efectos de los fármacos , Activación de Linfocitos/genética , Trastornos Linfoproliferativos/diagnóstico por imagen , Trastornos Linfoproliferativos/tratamiento farmacológico , Trastornos Linfoproliferativos/enzimología , Trastornos Linfoproliferativos/patología , Trastornos Linfoproliferativos/virología , Neumonía Viral/tratamiento farmacológico , Neumonía Viral/patología , Mutación Puntual , Rituximab , Tomografía Computarizada por Rayos XRESUMEN
INTRODUCTION AND OBJECTIVES: Lactate dehydrogenase (LDH) is found in almost all tissues of the body and five different isoenzymes are known (LDH-1 to LDH-5). LDH can be elevated in many pathological conditions. We have observed serum LDH to be increased in patients with chronic cough. We wanted to confirm this finding, study the reproducibility and determine the origin of the LDH. METHODS: Patients prospectively seen at the Hull Cough Clinic had total and specific LDH isoenzyme levels in serum determined. A subgroup of patients also had a serum creatine phosphokinase (CK) measured. Patients completed cough symptom scores and the Hull Airway Reflux Questionnaire (HARQ). Spirometry was performed. RESULTS: Eighty-three patients were included. Forty-two percent had LDH values above the reference range and 78% had LDH values in the fourth quartile of the reference range or above. This increase in LDH was predominantly because of a rise in isoenzymes 4 and 5. The increase in LDH was found to be reproducible at 8 weeks. Ten percent had CK values above the normal range. There was no correlation observed between LDH values and the cough scores, HARQ scores or lung function. CONCLUSION: Serum LDH levels are elevated in a substantial proportion of patients with chronic cough. This rise is likely to be due to airway inflammation known to be associated with chronic cough.
Asunto(s)
Tos/enzimología , Tos/patología , L-Lactato Deshidrogenasa/sangre , Adulto , Anciano , Biomarcadores/sangre , Estudios de Casos y Controles , Enfermedad Crónica , Estudios de Cohortes , Tos/etiología , Creatina Quinasa/sangre , Femenino , Humanos , Masculino , Persona de Mediana Edad , Reproducibilidad de los Resultados , Índice de Severidad de la Enfermedad , EspirometríaRESUMEN
BACKGROUND AND OBJECTIVE: Cyclooxygenase (COX) is an enzyme that converts arachidonic acid to prostanoids. There are two isoforms of COX, namely COX-1 and COX-2. COX-2 is highly inducible by several stimuli and is associated with inflammation. Recent studies have shown that COX-2 is upregulated in the airway epithelium of patients with asthma but little is known about the role it plays in cough, a common symptom of bronchial asthma. This study was designed to investigate the role of COX-2 in cough reflex sensitivity in patients with asthma. PATIENTS AND METHODS: The effect of etodolac, a potent COX-2 inhibitor, on cough response to inhaled capsaicin was examined in 17 patients with stable asthma in a randomized, placebo-controlled crossover study. Capsaicin cough threshold, defined as the lowest concentration of capsaicin eliciting 5 or more coughs, was measured as an index of airway cough reflex sensitivity. RESULTS: The geometric mean (geometric SEM) cough threshold was significantly increased after a 2-week treatment program with oral etodolac (200 mg twice a day) compared with placebo (36.7 [1.2] vs 21.6 [1.2] gM, P<.02). CONCLUSIONS: These findings indicate that COX-2 may be a possible modulator augmenting airway cough reflex sensitivity in asthmatic airways.
Asunto(s)
Asma/enzimología , Tos/enzimología , Ciclooxigenasa 2/inmunología , Inhibidores de la Ciclooxigenasa/farmacología , Etodolaco/farmacología , Adulto , Anciano , Anciano de 80 o más Años , Asma/tratamiento farmacológico , Asma/inmunología , Capsaicina/inmunología , Tos/tratamiento farmacológico , Tos/inmunología , Estudios Cruzados , Inhibidores de la Ciclooxigenasa/uso terapéutico , Interacciones Farmacológicas , Etodolaco/uso terapéutico , Femenino , Volumen Espiratorio Forzado , Humanos , Masculino , Persona de Mediana Edad , Estadísticas no Paramétricas , Capacidad VitalRESUMEN
We have identified a distinct subtype of airway vagal afferent nerve that plays an essential role in regulating the cough reflex. These afferents are exquisitely sensitive to punctate mechanical stimuli, acid, and decreases in extracellular chloride concentrations, but are insensitive to capsaicin, bradykinin, histamine, adenosine, serotonin, or changes in airway intraluminal pressures. In this study we used intravital imaging, retrograde neuronal tracing, and electrophysiological analyses to characterize the structural basis for their peculiar mechanical sensitivity and to further characterize the regulation of their excitability. In completing these experiments, we uncovered evidence for an essential role of an isozyme of Na(+)-K(+) ATPase in regulating cough. These vagal sensory neurons arise bilaterally from the nodose ganglia and are selectively and brilliantly stained intravitally with the styryl dye FM2-10. Cough receptor terminations are confined and adherent to the extracellular matrix separating the airway epithelium and smooth muscle layers, a site of extensive remodeling in asthma and chronic obstructive pulmonary disease. The cough receptor terminals uniquely express the alpha(3) subunit of Na(+)-K(+) ATPase. Intravital staining of cough receptors by FM2-10, cough receptor excitability in vitro, and coughing in vivo are potently and selectively inhibited by the sodium pump inhibitor ouabain. These data provide the first detailed morphological description of the peripheral terminals of the sensory nerves regulating cough and identify a selective molecular target for their modulation.
Asunto(s)
Tos/fisiopatología , Reflejo/fisiología , Células Receptoras Sensoriales/fisiología , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Nervio Vago/fisiología , Animales , Adhesión Celular , Tos/enzimología , Epitelio/anatomía & histología , Matriz Extracelular/fisiología , Cobayas , Isoenzimas/metabolismo , Masculino , Músculo Liso/anatomía & histología , Ganglio Nudoso/anatomía & histología , Ganglio Nudoso/citología , Ganglio Nudoso/fisiología , Ratas , Células Receptoras Sensoriales/citología , Células Receptoras Sensoriales/enzimología , Tráquea/anatomía & histología , Tráquea/citología , Tráquea/fisiología , Nervio Vago/anatomía & histología , Nervio Vago/citologíaRESUMEN
Angiotensin-converting enzyme inhibitors (ACEIs) have been used in the treatment of various cardiovascular diseases. Despite the therapeutic benefits of ACEIs, there are several reported side effects, including chronic cough, angioedema and anaphylactoid reactions. These adverse events cannot be explained by the vasodilatory effects of this group of medications. Preliminary studies have shown that patients with a history of developing these side effects have a lower activity of an enzyme called aminopeptidase-P. This enzyme has an important role in degrading bradykinin. This defect in enzymatic activity can be partially explained by genetic variation. Using genome-wide screening strategies, the locus (loci), gene(s) and untimely polymorphisms that explain the low enzymatic activity and side effects can be identified.
Asunto(s)
Anafilaxia/inducido químicamente , Angioedema/inducido químicamente , Inhibidores de la Enzima Convertidora de Angiotensina/efectos adversos , Tos/inducido químicamente , Aminopeptidasas/genética , Aminopeptidasas/metabolismo , Anafilaxia/enzimología , Anafilaxia/genética , Angioedema/enzimología , Angioedema/genética , Bradiquinina/metabolismo , Tos/enzimología , Tos/genética , Humanos , Lisina Carboxipeptidasa/genética , Lisina Carboxipeptidasa/metabolismo , Mutación , Peptidil-Dipeptidasa A/metabolismo , Polimorfismo GenéticoRESUMEN
BACKGROUND: Gastrooesophageal reflux (GER) is a frequent cause of chronic cough. Several investigators have indicated that inhibitors of H(+)K(+)ATPase (proton pump inhibitors; PPIs) could relieve coughing via inhibition of acid reflux. However, we considered that PPIs might directly inhibit increased cough reflex sensitivity. OBJECTIVE: The present study was designed to examine whether PPIs directly inhibit antigen-induced increase in cough reflex sensitivity and to elucidate the mechanism. METHODS: Actively sensitized guinea-pigs were challenged with aerosol antigen (ovalbumin, OVA) and cough reflex sensitivity to inhaled capsaicin was measured 24 h later. The PPIs (omeprazole and rabeprazole) or the histamine H(2) blocker cimetidine were administered intraperitoneally 1 h before OVA challenge and before measuring cough reflex sensitivity, then bronchoalveolar lavage fluid (BALF) was immediately collected. The pH of the fluid obtained by bronchial washing was determined after examining the effect of rabeprazole on the cough response to capsaicin. RESULTS: The number of coughs elicited by capsaicin was significantly increased 24 h after challenge with OVA compared with saline, indicating antigen-induced increase in cough reflex sensitivity. Both PPIs dose dependently and significantly inhibited antigen-induced cough hypersensitivity. Omeprazole did not influence the antigen-induced increase in the total number of cells or ratio (%) of eosinophils in BALF. Cimetidine did not affect the antigen-induced cough hypersensitivity or cellular components of BALF. The pH of the bronchial washing fluid was significantly decreased in antigen-challenged animals. Rabeprazole did not affect the antigen-induced decrease in the pH of bronchial washing fluid. CONCLUSION: These findings show that PPIs, but not histamine H(2) blockers, can directly decrease antigen-induced cough reflex hypersensitivity, while the mechanism remains unclear.
Asunto(s)
Bencimidazoles/uso terapéutico , Tos/prevención & control , Omeprazol/análogos & derivados , Omeprazol/uso terapéutico , Inhibidores de la Bomba de Protones , 2-Piridinilmetilsulfinilbencimidazoles , Alérgenos , Animales , Bronquios/química , Líquido del Lavado Bronquioalveolar , Capsaicina , Cimetidina/uso terapéutico , Tos/enzimología , Tos/inmunología , Relación Dosis-Respuesta a Droga , Cobayas , ATPasa Intercambiadora de Hidrógeno-Potásio/análisis , Antagonistas de los Receptores H2 de la Histamina/uso terapéutico , Concentración de Iones de Hidrógeno , Inmunohistoquímica/métodos , Irritantes , Ovalbúmina , Rabeprazol , Tráquea/químicaRESUMEN
This study evaluates the effects of a copper amine oxidase (histaminase) purified from the pea seedling as a free or immobilized enzyme on asthmalike reactions to inhaled antigen in actively sensitized guinea pig in vivo. Male albino guinea pigs, sensitized with ovalbumin, were challenged with the antigen given by aerosol; free histaminase or CNBr-Sepharose immobilized histaminase was given intraperitoneally (20 microg, 3 or 24 h before antigen challenge) or by aerosol (4 microg, 30 min before or during ovalbumin aerosol). The following parameters were examined: latency time for the onset of respiratory abnormalities, cough severity score, and occurrence and duration of dyspnea. We also evaluated lung histopathology, mast cell degranulation, and lung myeloperoxidase and malonydialdehyde levels. Histaminase significantly reduced the severity of cough and the occurrence of dyspnea and delayed the onset of respiratory abnormalities. Both enzymes prevented bronchial constriction, pulmonary air space inflation, leukocyte infiltration (evaluated as myeloperoxidase activity), and lipoperoxidation of cell membranes (evaluated as malonyldialdehyde production). No relevant differences in pharmacological potency were noted between free or immobilized enzyme. This study provides evidence that histaminase counteracts acute allergic asthmalike reaction in actively sensitized guinea pigs, raising the possibility of new therapeutic strategies for allergic asthma in humans.
Asunto(s)
Amina Oxidasa (conteniendo Cobre)/uso terapéutico , Antígenos/administración & dosificación , Pisum sativum , Hipersensibilidad Respiratoria/tratamiento farmacológico , Hipersensibilidad Respiratoria/enzimología , Administración por Inhalación , Aerosoles , Amina Oxidasa (conteniendo Cobre)/aislamiento & purificación , Amina Oxidasa (conteniendo Cobre)/farmacología , Animales , Asma/tratamiento farmacológico , Asma/enzimología , Asma/inmunología , Tos/tratamiento farmacológico , Tos/enzimología , Tos/inmunología , Enzimas Inmovilizadas/sangre , Cobayas , Inmunización/métodos , Inyecciones Intraperitoneales , Pulmón/efectos de los fármacos , Pulmón/enzimología , Masculino , Ovalbúmina/administración & dosificación , Ovalbúmina/inmunología , Pruebas de Función Respiratoria , Hipersensibilidad Respiratoria/inmunología , PlantonesRESUMEN
Several reports have demonstrated that the number of capsaicin-induced coughs is increased in the presence of prostaglandins in the airway. Moreover, it has been reported that the expression of cyclooxygenase-2, which converts arachidonic acid to prostaglandins, was found in cultured human airway epithelial cells in the absence of inflammatory cytokine stimulation. Thus, it is possible that cyclooxygenase-2 inhibitor may produce an antitussive effect. To test this hypothesis, we investigated the effects of N-[2-(cyclohexyloxy)-4-nitrofenyl]-methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, and 5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethyl-pyrazole (SC-560), a selective cyclooxygenase-1 inhibitor, on capsaicin-induced coughs in guinea pigs. NS-398 (1-10 mg/kg, p.o.) dose-dependently and significantly reduced the number of capsaicin-induced coughs. In contrast, SC-560 (10 mg/kg, p.o.) did not reduce the number of capsaicin-induced coughs. The antitussive effect of NS-398 (10 mg/kg, p.o.) was not antagonized by pretreatment with methysergide (3 mg/kg, i.p.), a non-selective serotonin (5-HT) receptor antagonist, or glibenclamide (10 mg/kg, i.p.), an ATP-sensitive K(+) channel blocker. Furthermore, although NS-398 did not significantly affect the cough reflex induced by substance P (10(-16) M), it significantly reduced the capsaicin-induced release of substance P in bronchoalveolar lavage fluid (BALF). The present findings clearly show that cyclooxygenase-2 inhibitor, but not cyclooxygenasez-1 inhibitor, has a potent antitussive effect. Furthermore, it is possible that the antitussive action of NS-398 does not depend on centrally acting mechanisms, since 5-HT receptors play an important role in the cough-depressant activities of centrally acting antitussive drugs. NS-398 may exert peripheral antitussive effects by inhibiting the release of substance P from capsaicin-sensitive afferent C-fibers in the airways. These results suggest that cyclooxygenase-2 inhibitors may have a therapeutic benefit in reducing coughs.
Asunto(s)
Antitusígenos/uso terapéutico , Tos/tratamiento farmacológico , Inhibidores de la Ciclooxigenasa/uso terapéutico , Nitrobencenos/uso terapéutico , Sulfonamidas/uso terapéutico , Animales , Tos/enzimología , Ciclooxigenasa 2 , Inhibidores de la Ciclooxigenasa 2 , Relación Dosis-Respuesta a Droga , Cobayas , Masculino , Prostaglandina-Endoperóxido Sintasas/metabolismoRESUMEN
BACKGROUND: It is unclear why some patients develop a chronic nonproductive cough. Angiotensin-converting enzyme (ACE) inactivates tussive peptides in the airways such as bradykinin and tachykinins. An insertion/deletion polymorphism in the ACE gene accounts for variation in ACE levels, and patients with the II genotype have lowest serum ACE levels compared with ID and DD genotypes. We hypothesized that the II genotype would be associated with increased risk of developing a chronic cough. MATERIALS AND METHODS: We recruited 47 patients (33 women), referred for evaluation of cough (median cough duration, 24 months; range, 2 to 240 months). Cough patients were evaluated using a comprehensive diagnostic protocol, and cough reflex sensitivity was measured using a capsaicin inhalation challenge. ACE genotyping was performed on DNA samples from patients using the polymerase chain reaction followed by agarose gel electrophoresis. ACE genotypes in patients with chronic cough were compared with those in 199 healthy control subjects. Serum ACE levels were determined using a colorimetric assay. RESULTS: Genotype frequencies for the ACE gene were similar between patients and control subjects. There was no correlation between capsaicin sensitivity and ACE genotypes or serum ACE levels. CONCLUSION: Susceptibility to develop chronic cough is not associated with ACE genotype.
Asunto(s)
Tos/enzimología , ADN/análisis , Peptidil-Dipeptidasa A/genética , Adolescente , Adulto , Anciano , Alelos , Capsaicina/uso terapéutico , Enfermedad Crónica , Tos/tratamiento farmacológico , Tos/genética , Electroforesis en Gel de Agar , Femenino , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Peptidil-Dipeptidasa A/sangre , Reacción en Cadena de la Polimerasa , Polimorfismo GenéticoRESUMEN
This review describes novel aspects of enzymes in the pertinent tissues of the airway and those associated with inflammatory cells. These include neutral endopeptidase, histamine N-methyltransferase, mast cell and neutrophil enzymes which have a potentially important role in the modulation of several airway functions such as bronchoconstriction, gland secretion, plasma extravasation and cough. Thus, regulation of enzyme activities in the airways may have new therapeutic implications in inflammatory diseases of airways.
Asunto(s)
Broncoconstricción/fisiología , Tos/enzimología , Sistema Respiratorio/enzimología , Animales , Asma/enzimología , Asma/fisiopatología , Bronquitis/enzimología , Bronquitis/fisiopatología , Permeabilidad Capilar , Enfermedad Crónica , Tos/fisiopatología , Fibrosis Quística/enzimología , Fibrosis Quística/fisiopatología , Humanos , Sistema Respiratorio/irrigación sanguínea , Sistema Respiratorio/metabolismoRESUMEN
Antes de la comercialización de los inhibidores de la enzima convertidora de angiotensina (I-ECA), la tos no era considerada como un efecto secundario de importancia. Hoy día sin embargo, la tos es reconocida como un efecto común de todos los I-ECA, siendo un poco más frecuente con enalapril, para el que se reporta una incidencia de 2,9 por ciento. La tos producida por los I-ECA es persistente, no productiva, empeora por las noches y al hablar. La tos es reversible, resolviéndose después de una semana de suspender el tratamiento. Se ha reportado que puede producirse mayor incidencia de este efecto secundario en mujeres